Skip to content

Clinical trials

Phase 1/2 Lymphoma, Mantle-Cell trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 1/2 Country / region: Australia Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20192
20201
20211
20231
20241
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting5
Completed2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca2
BeOne Medicines2
BeiGene1
CRISPR Therapeutics AG1
IGM Biosciences, Inc.1
Loxo Oncology, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell8
Leukemia, Lymphocytic, Chronic, B-Cell7
Lymphoma, Follicular6
Lymphoma, B-Cell, Marginal Zone5
Lymphoma, Non-Hodgkin4
Lymphoma, B-Cell3
Leukemia, B-Cell2
Lymphoma2
Lymphoma, Large B-Cell, Diffuse2
Recurrence2

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.